Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2025 10:35 ET | Source: Research and Markets

Anamorelin Market Forecast Report 2025-2030: A Breakthrough Therapeutic Agent for Cachexia Treatment

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "Anamorelin Market by Indication (Cancer Cachexia, Chronic Heart Failure Cachexia, Future Indications), Distribution Channel (Emerging Channels,...
November 15, 2012 05:10 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma Announces Top-Line Results of TZP-102 Phase 2b Trial

Preliminary Analysis Indicates Trial Did Not Meet Primary Endpoint Tranzyme to Host Conference Call Today at 8:00 am ET RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2012 (GLOBE NEWSWIRE) -- ...
November 08, 2012 16:30 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma Announces Third Quarter 2012 Financial Results

RESEARCH TRIANGLE PARK, N.C, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class...
October 25, 2012 05:10 ET | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012

RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss...